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The present study was designed to investigate the possible role of Mg 2+ in suppression of phosphoenolpyruvate carboxy kinase (PEPCK) enzyme via inhibition of FOXO1gene expression in liver and we also examined whether Mg contributes to decrease blood glucose in muscle via inhibiting FOXO1 gene and protein expression. Fifty rats in five groups of experiment were considered as; non-diabetic control (NDC), Mg -CD and Mg 2+ -NDC groups received 10 g/l of magnesium sulfate (MgSO 4 ) added to drinking water, and Ins-CD group received 2.5 U/kg of insulin. The blood glucose level and body weight were measured weekly. After 16 weeks, intraperitoneal glucose tolerance test (IPGTT) was done and blood samples were taken to determine the plasma levels of Mg and gastrocnemius muscle legs, and liver were isolated for both Forkhead transcription factor (FOXO1) and PEPCK enzyme genes and proteins expression. Administration of MgSO 4 improved IPGTT, lowered blood glucose levels and decreased FOXO1 and PEPCK genes and proteins expression in muscle and liver, while insulin just could decrease FOXO1 gene and protein expression in the muscle. These findings illustrated that MgSO 4 improved hyperglycemia via inhibition of FOXO1 gene and protein level in the muscle and liver, and it also decreased blood glucose level by prohibition of gluconeogenesis pathway in the liver. However, long time administration of insulin did not have any effect on liver.
Introduction
There are different pathways to regulate the blood sugar including the control of the key enzyme (phosphoenol pyruvate carboxykinase enzyme, PEPCK) activity of the gluconeogenesis pathway in the liver. Increasing the activity of this enzyme is one of the responsible factors to increase blood glucose in diabetic patients [1] . It is reported that PEPCK expressions is down-regulated by insulin [2] . The other way to improve glucose hemostasis is stimulating glucose transporter 4(GLUT4), gene expression and translocation from intracellular pool to the plasma membrane [3] . Insulin stimulates glucose uptake in adipose and muscle tissues by eliciting GLUT4 gene expression [4] .
In addition, Forkhead transcription factor (FOXO1) plays an important role in mediating insulin action and regulating target gene expression [5] . Some findings [6] indicate that FOXO1 is a negative regulator of insulin sensitivity in liver, adipocytes and pancreatic β-cells. FOXO1contains highly conserved Akt phosphorylation sites (Thr-24, Ser-253, and Ser-316) and its activity is regulated by Akt-mediated phosphorylation of these sites. Phosphorylated FOXO1 is excluded from the nucleus, thereby decreasing its transcriptional activity (7) . FOXO1 also stimulates the expression of phosphoenolpyruvate carboxy kinase (PEPCK) and glucose 6-phosphatase (G6P-ase) via direct binding of insulin response element (IRE) mapped in the promoters of these genes [7] . So over activity of the FOXO1 promotes diabetic hyperglycemia, dyslipidemia, and acute-phase response [5] . Recent studies demonstrated that insulin can suppress FOXO1 activity [8, 9] T been documented by us and others that magnesium (Mg 2+ ) deficiency occurs during diabetes induction [10] and Mg deficiency increases the activity of PEPCK and G6P-ase enzymes [11] , however; the mechanism of this phenomenon is not completely understood. Our previous findings support the hypothesis that magnesium could decrease blood glucose via an increase in GLUT4 mRNA expression not by increasing in insulin secretion [12] . Diabetes was induced by a single IP injection of 60 mg/kg streptozotocin dissolved in isotonic normal (STZ, Sigma Aldrich, Hamburg, Germany) and the same volume of normal saline was injected to the animals in the NDC group. At 10 days post STZ injection, fasting blood glucose level was determined and the presence of diabetes was confirmed by blood glucose levels of above 250 mg/dl. Animals in which the diabetes lasted for 16 weeks were defined as chronic diabetic. Ten days after diabetes induction, the Mg 2+ -CD and Mg
2+
-NDC groups received 10 g/l of MgSO 4 (Sigma Aldrich, Hamburg, Germany) added to their drinking water for 16 weeks. Water consumption was measured. Mg 2+ -treated chronic diabetic and Mg 2+ -treated non-diabetic control groups appeared to have significantly lower water consumption compared to chronic diabetic group (42 ± 2, 40 ± 2 and 203 ± 3.1 ml/ 24 h for Mg 2+ -treated chronic diabetic, Mg 2+ -treated non-diabetic control and chronic diabetic respectively). So the exact dose of MgSO 4 that rats were consuming was 0.42 g/24 h. The Ins-CD group received 2.5 U/kg of insulin (1/3 regular and 2/3 NPH, from Aksir Company Iran) for 16 weeks to keep the blood glucose around 100 ± 2 mg/dl [13] . Animals were monitored for blood glucose concentrations and body weight every week at 9 A M over the course of the experiment. Blood glucose was measured with an Ascensia ELITE XL glucometer and Ascensia Elite blood glucose test strips and body weight of all experimental was recorded using a digital weighing scale.
Intraperitoneal glucose tolerance test (IPGTT)
For IPGTT, the animals in all groups were subjected to 15 h overnight fastening, and were given 1.5 g of glucose (Sigma Aldrich, Hamburg, Germany) per kilogram of body weight via IP injection. Blood was drawn from the tail vein at 0, 10, 20, 30, 60, 90 and 120 min after glucose administration [14] .
Biochemical assay
Animals were anesthetized with ketamine HCl (50 mg/kg, IP, from Rotexmedica Trittau, Germany), then the animals were decapitated.
Blood samples were taken from the neck vascular trunk in order to determine the plasma levels of Mg by Micro plate reader (Biotek, USA) and appropriate kits (Zistshimi, Tehran, Iran).
Liver and muscle were isolated for FOXO1 gene and protein expression via Real-time PCR and immunohistochemistry methods respectively. The gene expression of PEPCK enzyme and their proteins in liver were also measured by Real-time PCR and ELISA (mybiosource,USA), respectively.
RNA extraction
The total RNA was extracted from muscle tissue using RNeasy Fibrous Tissue mini kit (Cat No.74704 QIAGEN, Germany) according to the manufacturer's protocol. Briefly, RNA was treated with 1 μl DNase-I in 37°C for 30 min and then 1 μl 50 mM EDTA was added. Then it was incubated in 65°C for 10 min for DNase inactivation. The extracted RNA was quantified by running on 1.5% agarose gel electrophoresis. The 18S and 28S RNA bands should be visualized under a transillumiator. The yield was quantified spectro-photometrically at 260 and 280 ηm by NanoDrop 1000 (Thermo, USA). The obtained proportion of 1.8 to 2.0 from indicated the quality of extracted RNA.
Total RNA from liver tissue was extracted using Iraizol kit, (RNA Biotech.IRAN) following the manufacturer's instruction.
cDNA synthesis and quantitative real-time PCR
The total RNA (2 μg) was reversely transcribed to cDNA using PrimeScript ™ RT Reagent kit Fast cDNA Synthesis Kit ready for Real Time (Cat. No.RR037 A, Takara, Japan) by applying random hexamer primer following the manufacturer's protocol. Quantitative RT-PCR was conducted on a Real-time PCR (Corbett, Rotor-Gene 6000, Australia) and SYBR Green (Takara, Japan) according to the manufacturer's instructions. All reactions were carried out in a terminal volume of 20 μl containing1μL of cDNA sample, 1 μl of the primers, 10 μL SYBR Green, 0/4 μL ROX and 7/6 μL of sterile double-distilled water for all β-actin, FOXO1 or PEPCK. The thermal cycling status for β-actin was an initial denaturation at 95°C for 3 min followed by 40 cycles of denaturation at 95°C for 10 s, annealing at 68°C for each primer for 30 s. For FOXO1: the thermal cycling status was an initial denaturation at 95°C for 3 min followed by 40 cycle of denaturation at 95°C for 10 s, annealing at 62°C for each primer for 30 s. Also for PEPCK the thermal cycling status was an initial denaturation at 95°C for 3 min followed by 40 cycles of denaturation at 95°C for 10 s and the annealing at 65°C for each primer for 30 s. All the standards and the samples measurements were repeated twice. Each PCR product was characterized by melting curve analysis. Expression levels of FOXO1and PEPCK were normalized by β-actin expression as the house-keeping gene and calculated through the 2 −ΔΔCT method. The sequence of specific primer sets for each gene, amplicon sizes and annealing temperature of the primers real-time PCR time was used (Table 1 ).
Immunohistochemistry
Five-micrometer sections of formalin-fixed paraffin-embedded tissue were cut and prepared for IHC staining. Processed through xylene -NDC groups (P < 0.001). and a graded alcohol series and treated with 3% hydrogen peroxide to eliminate the endogenous peroxidase activity prior to immune-staining and blocked with 5% normal goat serum. Slides were then treated with mouse anti-rat FOXO1 m Ab at 10 μg / ml (Santa Cruz Biotechnology, Santa Cruz, CA). After an overnight incubation, horse anti-mouse IgGbiotin (Vector Labs, Burlingame, CA) secondary antibody was added at a 1 : 200 dilution, followed by streptavidin -HRP (Jackson Labs, West Grove, PA) at 1 : 1000. Slides were developed with AEC Reagent (Zymed Laboratories, San Francisco, CA) and counterstained with hematoxylin (Sigma Co, St. Louis, MO). Cells were viewed and photographed under bright field.
Statistical analysis
Data is expressed as mean ± S.E.M. Differences among groups was evaluated by one-way and two-way ANOVA with the Tukey post-hoc test. The relative changes of gene expression were calculated by the 2 ˄−ΔΔCt formula, where ΔCt = C t (FOXO1 or PEPCK)-C t (β-actin) and
Ct demonstrates threshold cycle number. In addition, Spearman and Mann-Witney U-tests were used to investigate the expression pattern of target gene. Statistical analysis was carried out using SPSS-21 software. P < 0.05 was selected for acceptance of statistical significance.
Results
Before the intervention, there were no differences in blood glucose, IPGTT, body weight and plasma Mg level among the animals in each group.
Changes in blood glucose
Changes in feeding blood glucose were measured in all groups (Fig. 1A) . Diabetes induction caused blood glucose concentration to increase (418.33 ± 12.88 mg/dl) and blood glucose continued to be elevated (587 ± 9.57 mg/dl) 16 weeks after diabetes induction. Administration of MgSO 4 or insulin for 16 weeks (from day 10) caused the blood glucose concentrations in the Mg-CD and Ins-CD groups decreased (128.25 ± 0.62 mg/dl, 93 ± 15.99 mg/dl) respectively.
Effect of MgSO4 on intraperitoneal glucose tolerance test (IPGTT)
Before starting MgSO 4 and STZ administration, the IPGTT patterns for all groups were similar, and there were no significant differences between the groups when the glycemic response was expressed as the area under the curve (AUC) (data was not shown). However, after 16 weeks, the CD group displayed severe glucose intolerance (Fig. 1B) , which was significantly improved in the Mg 2+ -CD group to a degree that was judged effective ( 
Changes in the body weight and plasma magnesium levels
The body weight of CD animals was insignificantly decreased when compared to the levels in NDC animals; increased body weight was significantly observed after administration of Mg 2+ and insulin when compared to the levels in CD animals ( Fig. 2A) .
To find the concentration as well as duration of oral-administered Mg in plasma, changes in plasma Mg -CD and Ins-CD groups (P < 0.001) (Fig. 2B) .
Changes in FOXO1 and PEPCK gene expression
The average Ct obtained from Real-time PCR of five groups of examined rats as well as the effect of MgSO 4 and insulin in expression of PEPCK and FOXO1 in liver and muscle have been showed through Fig. 3A, C and Fig. 4A 
Discussion
Diabetes is recurrently linked with both extracellular and intracellular Mg shortages [15] . Insulin and glucose are main supervisors of Mg metabolism. Intracellular Mg plays an important role in changeable insulin action, insulin-mediated-glucose-uptake and insulin sensitivity [15] . Our previous study showed that oral Mg 2+ administration for 8 weeks played a crucial role in glucose hemostasis through attenuated GLUT4 gene expression [3] while the mechanism of this phenomenon was not clear. So, the present study was designed to investigate to examine whether Mg 2+ contributes to the activation of , after 16 weeks, weight was significantly increased compared to other groups due to the maintenance of fat storage in the body. Based on the current results, it seems that Mg 2+ administration is not suitable for NDC group, because it interrupts the electrolyte balance. Extreme hepatic sugar manufacture is a donating factor to fasting hyperglycemia in diabetes. Insulin destroys hepatic glucose creation via preventing the expression of two important gluconeogenic enzymes [16] . Studies confirmed that practical inhibition of FOXO1is related to decreased hepatic gluconeogenic activity and improved fasting blood glucose in diabetic animals [17] . Type 2 diabetes mellitus, obesity and insulin deficiency are accompanying diminished regulation of GLUT4 gene expression and increased blood glucose level [16] . On the other hand insulin unplugs FOXO1 through the PI3K/Akt pathway. FOXO1 factors, in turn, activate upstream signaling factors that control both insulin sensitivity and glucose metabolism [18, 19] gene was suppressed in this group. So in the liver the mRNAs for PEPCK remains high and gluconeogenesis continues to prevent of hypoglycemia in non-diabetic rats by Mg 2+ administration.
Researcher showed that under normal conditions, dietary glucose stimulates insulin secretion from the pancreas [20] . The insulin prevents of FOXO1 phosphorylation which in turn down regulates genes required for gluconeogenesis, most prominently PEPCK [20] . The result is a decrease in hepatic glucose output, which helps to keep blood glucose low [21, 22] . But the results of the present study showed that FOXO1 gene expression was not suppressed by insulin in the liver, whereas mRNA for PEPCK in liver was blocked by insulin and gluconeogenesis pathway was stopped by the other mechanism.
Conclusion
Overall, the results of this study showed that Mg 2+ is more effective than insulin in controlling blood glucose and prevent of gluconeogenesis pathway in liver while Mg 2+ has both positive liver and the muscle effects.
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